Dear Reader,

If your email inbox and newsfeed are anything like mine, you’ve been inundated with biotech investing ideas lately.

Some sources seem to have a good handle on the science, and are offering balanced opinions. Others are just chasing hype and the popular “coronavirus vaccine” fervor.

Capital is indeed flowing into the biotech sector in an unprecedented way—and it is more than fair to say biotech is booming.

Over the past couple of weeks, my colleagues Chris Wood and Jake Weber have been sharing with you key movements being made in biotech.

You’ve read how the biotech market hasn’t looked this good in years. The iShares Nasdaq Biotechnology ETF (IBB), the most liquid proxy for US biotech stocks, has soared nearly 30% over the past 12 months—almost three times the return of the S&P 500 over the same period.

You’ve seen how much venture capitalists are pouring into almost every sub-sector of biotech. RNA/DNA-related biologics alone saw a 78% jump in investment in 2019.

The demand for a vaccine has pushed all areas of biotech into overdrive, and will benefit our healthcare system tangentially for years to come.

The exceptional potential for short- to mid-term gains would make even the most conservative among us wonder where we should be investing.

With so much information to sift through, it can be hard to know where to start.

That’s where our chief healthcare and biotech experts, Chris Wood and Jake Weber, come in.

With 30 years of combined expertise, both Chris and Jake have put their energy into identifying biotech’s most profitable opportunities—all while mitigating risk.

Because many investors are newly interested in biotech, they have offered to open a “Biotech Question & Answer Forum.” 

Simply click this link to enter the Forum and ask Chris and Jake your biotech-related questions.

It is important to ask your questions now as this Forum will only remain active until June 29.

During that time, you will benefit from having your questions answered by biotech experts who truly want to help you out.

Whether you want to know how to get started, what sub-sectors to follow, or what trends to keep your eye on—Chris and Jake have answers.

Access the Forum now and get answers to your most pressing biotech questions.

These are exciting times to be a biotech investor—if you know where to put your money.

Ed D’Agostino
Publisher, Mauldin Economics

P.S. It is important to note that neither Chris nor Jake will be able to provide individual investment advice.